Publication date: Apr 06, 2019
SAN RAFAEL, Calif. , April 5, 2019 /PRNewswire/ — AIM at Melanoma announces the grand opening of the first branch of the International Melanoma Tissue Bank Consortium (IMTBC) at the University of Pittsburgh Medical Center (UPMC), Hillman Cancer Center.
The IMTBC is a global first because of the following combination of factors: “The primary tumor is the holy grail of resources for melanoma researchers,” says John M. Kirkwood, MD, Usher Professor of Medicine, Dermatology and Translational Science and co-Leader, Melanoma and Skin Cancer Program, UPMC Hillman Cancer Center.
“Fifteen years ago, many researchers told me that a collaborative fresh-frozen primary tissue bank would propel research, but they also told me it would be impossible to accomplish,” says Val Guild, the Founder & President of AIM at Melanoma, who lost her 26 year old daughter, Charlie, to the disease in 2003.
- Melanoma-induced reprogramming of Schwann cell signaling aids tumor growth.
- WNT1-inducible signaling pathway protein 1 (WISP1/CCN4)